Palantir announced a major strategic partnership with Cognizant aimed at accelerating AI-driven modernization across the healthcare and enterprise sectors, causing shares to rebound sharply.
- The deal further validates Palantir's successful commercial expansion, which recently reported 137% U.S. commercial revenue growth.
- Shares closed +3.95% on February 6, 2026, amidst a broader technology sector rally following a week of volatility.